Insider · CIK 0001008377
Lisa A Conte
Files at JAGX (Jaguar Health, Inc.). First filing -, latest -.
Lisa A Conte files SEC Form 4 as CEO, president and director at JAGX (Jaguar Health, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Lisa A Conte has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 11, 2025 | JAGX Jaguar Health, Inc. | AGrant or award Common Stock | +28,592 | $0.00 | $0 | 29,258 | Jan 21, 2026 |
| Dec 11, 2025 | JAGX Jaguar Health, Inc. | AGrant or award Stock Option (right to buy)derivative | +28,592 | $0.00 | $0 | 28,592 | Jan 21, 2026 |
| Jun 24, 2025 | JAGX Jaguar Health, Inc. | DDisposition to issuer Convertible Promissory Notederivative | -9,000 | $50,000.00 | $450M | 0 | Jun 26, 2025 |
| Jun 24, 2025 | JAGX Jaguar Health, Inc. | AGrant or award Convertible Promissory Notederivative | +9,462 | $50,000.00 | $473M | 9,462 | Jun 26, 2025 |
| Jun 24, 2025 | JAGX Jaguar Health, Inc. | AGrant or award Warrant to Purchase Common Stockderivative | +18,262 | - | - | 9,000 | Jun 26, 2025 |
| May 17, 2025 | JAGX Jaguar Health, Inc. | MOption exercise Common Stock | +2 | - | - | 666 | May 20, 2025 |
| May 17, 2025 | JAGX Jaguar Health, Inc. | MOption exercise Restricted stock unitsderivative | -2 | $0.00 | $0 | 0 | May 20, 2025 |
| Mar 31, 2025 | JAGX Jaguar Health, Inc. | POpen-market purchase Convertible Promissory Notederivative | +9,000 | $50,000.00 | $450M | 9,000 | Apr 2, 2025 |
| Mar 31, 2025 | JAGX Jaguar Health, Inc. | POpen-market purchase Warrant to Purchase Common Stockderivative | +9,000 | - | - | 9,000 | Apr 2, 2025 |
Questions about Lisa A Conte
Answered from the filings on this page, as of the latest one.
Is Lisa A Conte buying or selling?
Lisa A Conte has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Lisa A Conte's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Lisa A Conte has 0.
Where does Lisa A Conte file Form 4?
Lisa A Conte has filed Form 4 at JAGX (Jaguar Health, Inc.) as See Remarks. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.